Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: A retrospective analysis

Anticancer Research

Volumn 28, Issue 1 B, 2008, Pages 543-549

  Papadoniou, Nikitas ^a,b   Kosmas, Christos ^a,c   Gennatas, Kostadinos ^a,d   Polyzos, Aris ^e   Mouratidou, Despina ^a,f   Skopelitis, Elias ^b   Tzivras, Michalis ^b   Sougioultzis, Stavros ^b   Papastratis, George ^g   Karatzas, Gavrilos ^b   Papalambros, Efstathios ^b,d   Tsavaris, Nikolas ^a,b,h  

^a Hellenic Oncology Research Group   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c METAXA CANCER HOSPITAL   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

^e Oncology Unit   (Greece)

^f THEAGENIO CANCER HOSPITAL   (Greece)

^g G GENNIMATAS GENERAL HOSPITAL   (Greece)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Chemotherapy; Pancreatic carcinoma; Prognostic factors; Surgical therapy; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; ADVANCED CANCER; ARTICLE; ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MULTIVARIATE ANALYSIS; PALLIATIVE THERAPY; PANCREAS ADENOCARCINOMA; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; WEIGHT REDUCTION;

ADENOCARCINOMA; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 40549086579     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A Feuer EJ and Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 55: 10-30, 2005.
2. Anderson KE, Potter JD and Mack TM: Pancreatic cancer. In: Jr Cancer Epidemiology and Prevention. Schottenfeld D, Fraumeni JF (eds.). New York: Oxford University Press, pp. 725-771, 2005.
3. Niederhuber JE, Brennan MF and Menck HR: The National Cancer Data Base Report on pancreatic cancer. Cancer 76: 1671-1677, 1995.
4. Reber HA and Gloor B: Radical pancreatectomy. Surg Oncol Clin North Am 7: 157-163, 1998.
5. Fong Y, Blumgart LH, Fortner JG and Brennan MF: Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg 222: 426-437, 1995.
6. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow LB and Abrams RA: Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226: 248-260, 1997.
7. Conlon KC, Klimstra DS and Brennan MF: Long term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5 year survivors. Ann Surg 223: 273-279, 1996.
8. Sperti C, Pasquali C, Piccoli A and Pedrazzoli S: Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 83: 625-631, 1996.
9. Magistrelli P, Antinori A, Crucitti A, Le Greca A, Masetti R Coppola R, Nuzzo G and Picciocchi A: Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol 74: 36-40, 2000.
10. Matsuno S, Egawa S, Shibuya K, Shimamura H, Sunamura M, Takeda K, Katoh H, Okada S, Suda K, Nakao A, Isaji S, Hiraoka T, Hosotani R and Imaizumi T: Pancreatic cancer: current status of treatment and survival of 16071 patients diagnosed from 1981 1996, using the Japanese National Pancreatic Cancer Database. Int J Clin Oncol 5: 153-157, 2000.
11. Link KH, Gansauge F, Goerich J, Leder G, Rillinger N and Berger HG: Palliative and adjuvant regional chemotherapy in pancreatic cancer. Eur J Surg Oncol 23: 409-414, 1997.
12. Li D, Xie K, Wolff R and Abbruzzese JL: Pancreatic cancer. Lancet 363: 1049-1057, 2004.
13. Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, Zahurak ML, Dooley WC, Coleman J, Sauter PK, Pitt HA, Lillemoe KD and Cameron JL: Pancreaticoduodenectomy for pancreatic adenocarcinoma: prospective adjuvant chemoradiation improves survival: a prospective, single institution experience. Ann Surg 225: 621-636, 1997.
14. Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boitnott JK, Seidler AJ and Coleman J: Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 161: 120-125, 1991.
15. Spitz FR, Abbruzzese JL, Lee JE, Pisters PW, Lowy AM, Fenoglio CJ, Cleary KR, Janjan NA, Goswitz MS, Rich TA and Evans DB: Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 15: 928-937, 1997.
16. Miller AR, Robinson EK, Lee JE, Pisters PW, Chiao PJ, Lenzi RL, Abbruzzese JL and Evans DB: Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. Surg Oncol Clin North Am 7: 183-197, 1998.
17. Takeuchi M, Kondo S, Sugiura H and Katoh H: Pre operative predictors of short term survival after pancreatic cancer resection. Hepato Gasterenterology 45: 2399-2403, 1998.
18. Cubiella J, Castells A, Fondevila C, Sans M, Sabater L, Navarro S and Fernandez Cruz L: Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials. Am J Gastroenterol 94: 1271-1278, 1999.
19. Ikeda M, Okada S, Tokuuye K, Ueno H and Okusaka T: Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy.Cancer 91: 490-495, 2001.
20. Ueno H, Okada S, Okusaka T and Ikeda M: Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy. Oncology 59: 296-301, 2000.
21. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH and Lillemoe KD: Resected adenocarcinoma of the pancreas 616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4: 567-579, 2000.
22. Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS and Coleman J: One hundred and forty five consecutive pancreaticoduodenectomies without mortality. Ann Surg 217: 430-438, 1993.
23. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, Dooley WC, Coleman J and Pitt HA: Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221: 721-733, 1995.
24. Geer RJ and Brennan MF: Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165: 68-73, 1983.
25. Nitecki SS, Sarr MG, Colby TV and van Heerden JA: Long term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221: 59-66, 1995.
26. Kloppel G, Solcia E, Longnecker DS, Capella C and Sobin LH: Histological Typing of Tumours of the Exocrine Pancreas (2nd edn.) WHO International Histological Classification of Tumours. Berlin, Springer Verlag, 1996.
27. Sobin LH and Wittekind Ch (eds.): UICC TNM Classification of Malignant Tumors (5th ed.). New York, John Wiley & Sons, Inc., 1997.
28. Talar Wojnarowska R, Gasiorowska A, Strzelczyk J, Janiak A and Malecka Panas E: Prognostic factors in the operative and palliative treatment of pancreatic cancer. Neoplasma 50: 383-387, 2003.
29. Birk D, Fortnagel G, Formentini A and Berger HG: Small carcinoma of the pancreas. Factors of prognostic relevance. J Hepatobiliary Pancreat Surg 5: 450-454, 1998.
30. Takai S, Satoi S, Toyokawa H, Yangimoto H, Sugimoto N, Tsuji K, Araki H, Matsui Y, Imamura A, Kwon AH and Kamiyama Y: Clinopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single institution experience. Pancreas 26: 243-249, 2003.
31. Bakkevold KE and Kambestad B: Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short term results. Ann Surg 217: 356-368, 1993.
32. Gebhardt C, Meyer W, Reichel M and Wunsch PH: Prognostic factors in the operative treatment of ductal pancreatic carcinoma. Langenbecks Arch Surg 385: 14-20, 2000.
33. Manabe D: Clinopathologic and molecular studies for the mechanism of recurrence after resection of pancreatic cancer. Jpn J Gastroenterol Surg 34: 1702-1712, 2001.
34. Fernandez del Castillo C and Warshaw AL: Laparoscopy for staging in pancreatic carcinoma. Surg Oncol 2: 25-29, 1993.
35. Fernandez del Castillo C and Warshaw AL: Pancreatic cancer. Laparoscopic staging and peritoneal cytology. Surg Oncol Clin N Am 7: 135-142, 1998.
36. Micke O, Bruns F, Schafer U, Kurowski R, Horst E and Willich N: CA 19-9 in the therapy monitoring and follow up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy. Anticancer Res 23: 835-840, 2003.
37. Ziske C, Schlie C, Gorschluter M, Glasmacher A, Mey U, Strehl J, Sauerbruch T and Schmidt Wolf IG: Prognostic value of CA 19 9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine. Br J Cancer 89: 1413-1417, 2003.
38. Cady B, Jenkins RL, Steele GD, Lewis D, Stone MD, McDermott WV, Jessup JM, Bothe A, Lalor P, Lovett EJ, Lavin P and Linehan DC: Surgical margin in hepatic resection for colorectal metastasis. A critical and improvable determinant of outcome. Ann Surg 227: 566-571, 1998.
39. Safi F, Schlosser W, Falkenreck S and Beger HG: CA19-9 serum course and prognosis of pancreatic cancer. Int J Pancreatology 20: 155-161, 1996.
40. Okusaka T, Shuichi O, Hideki U, Ikeda M, Shimada K, Yamamoto J, Kosuge T, Yamasaki S, Fukushima N and Sakamoto M: Abdominal pain in patients with resectable pancreatic cancer with reference to clinopathologic findings. Pancreas 22: 279-284, 2001.
41. Fitzgerald PJ: The pathology of pancreatic cancer and its possible relationship to pain. J Pain Sympt Manage 3: 171-175, 1998.